Profile for Minerva Neurosciences, Inc (NERV)
« Back to company indexNERV Chatter Timeline
Stock Ticker for NERV
Most Active Tweeters for NERV
| User | Tweets |
|---|---|
| @AmericanBanking | 3 |
| @ConsumerFeed | 3 |
| @QuantchaIdeas | 3 |
| @42Stocks | 3 |
| @ThisLincolnian | 2 |
Recent Tweets for NERV
 |
@dakotafinancial Zacks: Brokerages Expect Minerva Neurosciences Inc $NERV to Announce -$0.35 EPS https://t.co/D6k4q0vy4b May 25th 2018, 11:05pm |
 |
@TheMarketsDaily Zacks: Brokerages Expect Minerva Neurosciences Inc $NERV Will Post Earnings of -$0.35 Per Share https://t.co/WoiWICLhPa May 25th 2018, 11:05pm |
 |
@WeekHerald Minerva Neurosciences Inc $NERV Expected to Announce Earnings of -$0.35 Per Share https://t.co/WDfgK8HBBW May 23rd 2018, 2:05pm |
 |
@WatchlistN -$0.35 Earnings Per Share Expected for Minerva Neurosciences Inc $NERV This Quarter https://t.co/49m1S7FMLk May 23rd 2018, 2:05pm |
 |
@biotrader4gain $NERV now over $8 looking really good . May 22nd 2018, 10:05pm |
 |
@QuantchaIdeas Big Gainer Alert: Trading today’s 7.1% move in MINERVA NEUROSCIENCES INC COM $NERV https://t.co/hLX8d2WqA2 https://t.co/NtBx5m1hhH May 22nd 2018, 2:05pm |
 |
@dailypoliticaln -$0.35 EPS Expected for Minerva Neurosciences $NERV This Quarter https://t.co/XjJqOuayJR May 21st 2018, 9:05am |
 |
@TickerReport Analysts Anticipate Minerva Neurosciences $NERV to Post -$0.35 Earnings Per Share https://t.co/dFeJKHL19N May 21st 2018, 9:05am |
 |
@TranscriptDaily Minerva Neurosciences $NERV Upgraded by ValuEngine to Sell https://t.co/shh9onaWCw May 21st 2018, 6:05am |
 |
@1MinuteStock Wondering about risks of $NERV? The 21-day volatility is 21.54% https://t.co/45O6VTP8gm May 20th 2018, 3:05pm |
 |
@SwingTradeBot Recent $NERV technical alerts: Expansion Pivot Buy Setup plus 10 more alerts... https://t.co/r4xrVkhmUO May 20th 2018, 2:05pm |
 |
@profit_m_c Corrected the stock $NERV no $NREV https://t.co/sCIiL0BL9f May 20th 2018, 11:05am |
|
@profit_m_c $NERV May 20th 2018, 11:05am |
 |
@ZolmaxNews Minerva Neurosciences $NERV Raised to Sell at ValuEngine https://t.co/Kbo9k1F9el May 20th 2018, 11:05am |
 |
@ThisLincolnian Minerva Neurosciences $NERV Raised to Sell at ValuEngine https://t.co/7G1nE68Kru May 20th 2018, 7:05am |
|
@WeekHerald ValuEngine Upgrades Minerva Neurosciences $NERV to “Sell” https://t.co/WTADoVulr0 May 19th 2018, 6:05am |
|
@WatchlistN Minerva Neurosciences $NERV Rating Lowered to Hold at Zacks Investment Research https://t.co/AQfGtHb8OD May 19th 2018, 4:05am |
 |
@ConsumerFeed Zacks Investment Research Downgrades Minerva Neurosciences $NERV to Hold https://t.co/iLa84jkN9L May 19th 2018, 4:05am |
|
@ConsumerFeed Zacks: Brokerages Anticipate Minerva Neurosciences $NERV Will Announce Earnings of -$0.35 Per Share https://t.co/kAvgAnEoyy May 18th 2018, 3:05pm |
 |
@AmericanBanking Zacks: Brokerages Anticipate Minerva Neurosciences $NERV Will Announce Earnings of -$0.35 Per Share https://t.co/sP4aV9WQQD #stocks May 18th 2018, 3:05pm |
 |
@registrarjourn Minerva Neurosciences $NERV Upgraded to Sell at ValuEngine https://t.co/yI5kNh8KbJ May 18th 2018, 1:05pm |
 |
@dispatchtribune Minerva Neurosciences $NERV Upgraded to Sell at ValuEngine https://t.co/ZxyMDVwOEq May 18th 2018, 1:05pm |
|
@QuantchaIdeas Big Gainer Alert: Trading today’s 12.8% move in MINERVA NEUROSCIENCES INC COM $NERV https://t.co/BvwIryeDEK https://t.co/h3k8Cj6UmS May 18th 2018, 12:05pm |
 |
@kkernttb $NERV nice breakout today https://t.co/zqRWLxf6oz May 18th 2018, 11:05am |
 |
@42Stocks https://t.co/Yv3FmVM723 $NERV Minerva Neurosciences notable market movement up 7.4% = $21.4 million gain.… https://t.co/PjRdOU9BAe May 18th 2018, 11:05am |
|
@TickerReport Zacks Investment Research Lowers Minerva Neurosciences $NERV to Hold https://t.co/fJbvFR7awl May 18th 2018, 11:05am |
|
@registrarjourn Zacks Investment Research Lowers Minerva Neurosciences $NERV to Hold https://t.co/dY0g9zkDrq May 18th 2018, 11:05am |
|
@dailypoliticaln Zacks Investment Research Lowers Minerva Neurosciences $NERV to Hold https://t.co/oRMnwR5R87 May 18th 2018, 11:05am |
 |
@Datamonitor_HC RT @Datamonitor_SY: While $NERV roluperidone's cognitive improvement data from its post-hoc analysis of its Phase II schizophrenia trial ma… May 18th 2018, 7:05am |
|
@AmericanBanking ValuEngine Upgrades Minerva Neurosciences $NERV to Sell https://t.co/590nNnoo22 #stocks May 17th 2018, 10:05pm |
 |
@ledgerzette Minerva Neurosciences $NERV Rating Increased to Sell at ValuEngine https://t.co/bEtYkiFZtY May 17th 2018, 10:05pm |
 |
@OlympiaReport Minerva Neurosciences $NERV Rating Increased to Sell at ValuEngine https://t.co/WPZe59sIpJ May 17th 2018, 10:05pm |
|
@QuantchaIdeas Big Gainer Alert: Trading today’s 13.1% move in MINERVA NEUROSCIENCES INC COM $NERV https://t.co/cRgjLSO4z7 https://t.co/9izpORe5WR May 17th 2018, 1:05pm |
|
@TranscriptDaily Minerva Neurosciences $NERV Rating Lowered to Hold at Zacks Investment Research https://t.co/YGiZTNWbfL May 17th 2018, 1:05pm |
 |
@MarketChmln $NERV stock gains 15.5%. View latest news. https://t.co/JNITqr7iir May 17th 2018, 12:05pm |
 |
@AllStar_Trading $NERV Entry 7.45 SL 7.25 PT 7.85 #AllStarTradingTeam May 17th 2018, 11:05am |
|
@42Stocks https://t.co/Yv3FmVM723 $NERV Minerva Neurosciences notable market movement up 13.5% = $37 million gain.… https://t.co/qrKkYG2Xqt May 17th 2018, 10:05am |
 |
@Briefingcom $NERV: Minerva Neurosciences announces publication of results demonstrating cognitive improvements in patients with… https://t.co/vgZ6CEknfA May 17th 2018, 10:05am |
|
@strong_bio RT @odibro: $NERV Journal of Clinical Psychiatry Publishes +VE Results of Cognitive Performance From Phase 2B Trial of Roluperidone https:… May 17th 2018, 9:05am |
 |
@AlertTrade MOST ACTIVE ALERT: $NERV MINERVA NEUROSCIENCES ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room May 17th 2018, 9:05am |
|
@1MinuteStock Do you know that #Book Value for $NERV is $3.4 https://t.co/jtURIWzhOA May 17th 2018, 9:05am |
|
@MarketChmln $NERV #MinervaNeurosciences gains in premarket trading. See the latest news. https://t.co/JNITqr7iir https://t.co/wuJvoYFIXm May 17th 2018, 9:05am |
 |
@TheGretzOne $NERV premarket short. https://t.co/RcyyvyPcjP May 17th 2018, 9:05am |
 |
@MarketCurrents Minerva Neurosciences' roluperidone shows treatment effect in schizophrenia patients; shares ahe... https://t.co/eH0ViLnWBm #premarket $NERV May 17th 2018, 9:05am |
|
@SwingTradeBot Recent $NERV technical alerts: Fell Below 50 DMA plus 8 more alerts... https://t.co/r4xrVkhmUO May 17th 2018, 9:05am |
 |
@OpenOutcrier $NERV (+13.1% pre) Minerva Neurosciences shares rise 5% on trial results for schizophrenia drug - MW https://t.co/WZB5N1seiu May 17th 2018, 9:05am |
 |
@Datamonitor_SY While $NERV roluperidone's cognitive improvement data from its post-hoc analysis of its Phase II schizophrenia tria… https://t.co/v7GuaOdU3X May 17th 2018, 8:05am |
 |
@scrooge_fs Positive clinical report for $NERV has been released #pennyStocks #stocks #stockMarket #StockTrading #trader #News May 17th 2018, 8:05am |
 |
@stocknewsdotcom $NERV Announces publication of results demonstrating cognitive improvements in patients with schizophrenia treated… https://t.co/yduY3glFfm May 17th 2018, 8:05am |
 |
@odibro $NERV Journal of Clinical Psychiatry Publishes +VE Results of Cognitive Performance From Phase 2B Trial of Roluperi… https://t.co/I2M6HI1tch May 17th 2018, 8:05am |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.